Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 444.70
-8.70 (-1.92%)
Apr 28, 2026, 5:01 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 19.06 million as of April 28, 2026. Its market cap has decreased by -68.42% in one year.
Market Cap
19.06M
Enterprise Value
-7.93M
Revenue
1.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
444.70
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 19.06M, a decrease of -72.58%. That is a compound annual growth rate of -7.13%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLight Life Sciences | 22.38M |
| XTL Biopharmaceuticals | 18.92M |
| Purple Biotech | 18.59M |
| Evogene | 29.63M |
| BioLineRx | 33.94M |
| Clal Biotechnology Industries | 52.70M |
| Matricelf | 81.36M |
| Geffen Residence & Renewal | 270.51M |